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We previously demonstrated that acute hypoperfusion in exercising human muscle causes
an immediate increase in vascular resistance that is followed by a partial restoration (less
than 100% recovery) of flow. In the current study we examined the contribution of α-
adrenergic vasoconstriction in the initial changes in vascular resistance at the onset of
hypoperfusion as well as in the recovery of flow over time. Nine healthy male subjects
(29±2) performed rhythmic forearm exercise (20% of maximum) during hypoperfusion
evoked by intra-arterial balloon inflation. Each trial included; baseline, exercise prior to infla-
tion, exercise with inflation, and exercise after deflation (3 min each). Forearm blood flow
(FBF; ultrasound), local (brachial artery), and systemic arterial pressure (MAP; Finometer)
were measured. The trial was repeated during phentolamine infusion (α-adrenergic recep-
tor blockade). Forearm vascular conductance (FVC; ml min−1 100 mmHg−1) and resistance
(mmHg ml min−1) was calculated from BF (ml min−1) and local MAP (mmHg). Recovery
of FBF and FVC (steady state inflation plus exercise value−nadir)/[steady state exercise
(control) value−nadir] with phentolamine was enhanced compared with the respective
control (no drug) trial (FBF=97±5% vs. 81±6%, P <0.05; FVC=126±9% vs. 91±5%,
P <0.01). However, the absolute (0.05±0.01 vs. 0.06±0.01 mmHg ml min−1; P =0.17)
and relative (35±5% vs. 31± 2%; P =0.41) increase in vascular resistance at the onset
of balloon inflation was not different between the α-adrenergic receptor inhibition and con-
trol (no drug) trials.Therefore, our data indicate that α-adrenergic mediated vasoconstriction
restricts compensatory vasodilation during forearm exercise with hypoperfusion, but is not
responsible for the initial increase in vascular resistance at the onset of hypoperfusion.
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INTRODUCTION
In animals, when blood flow is restricted and/or perfusion pres-
sure is reduced, the active muscle is capable of autoregulating its
blood flow (Stainsby, 1962; Jones and Berne, 1964; Britton et al.,
1985; Metting et al., 1986) via intrinsic control mechanisms (Jones
and Berne, 1964; Britton et al., 1985). Additionally, a reflex pres-
sor response contributes to the restoration of blood flow to under
perfused exercising muscle in dogs (Wyss et al., 1983; Sheriff et al.,
1987; Mittelstadt et al., 1994; O’leary and Sheriff, 1995; Laprad
et al., 1999). Using a novel balloon catheter model in the brachial
artery to reduce blood flow to contracting forearm muscles, we
previously demonstrated that local vasodilator and/or myogenic
mechanisms, rather than a pressor response, are responsible for
a substantial portion of the restoration of flow to hypoperfused
exercising human muscle (Casey and Joyner, 2009b). In subse-
quent studies we found that nitric oxide- and adenosine-, but not
prostaglandin-, mediated vasodilation play a substantial role in the
compensatory flow response to hypoperfusion (Casey and Joyner,
2009a, 2011a,c).
Collectively, our series of studies (Casey and Joyner, 2009a,b,
2011a,c) demonstrated that there is only partial compensation of
flow (<100% recovery) in response to local reductions in oxygen
availability via hypoperfusion. This is in contrast to other condi-
tions in which oxygen availability is decreased (e.g., hypoxia and
anemia). Under these conditions there is a compensatory vasodila-
tion that mirrors the decrease in oxygen content (Gonzalez-Alonso
et al., 2006; Wilkins et al., 2006; Casey et al., 2010). Interestingly,
our hypoperfusion studies also revealed an initial increase in vas-
cular resistance in the forearm at the onset of balloon inflation that
progressively decreases over the inflation period. The initial rise in
vascular resistance in these studies is in contrast to the classic view
of autoregulation (a decrease in perfusion pressure is followed by a
reduction in resistance to blood flow through the muscle; Stainsby,
1962; Granger et al., 1976; Britton et al., 1985; Ping and Johnson,
1992). However, the initial increase in vascular resistance is not
unprecedented in that an immediate increase in vascular resistance
has also been reported to occur in isolated perfused skeletal muscle
of dogs (Jones and Berne, 1964). The reason for the initial increase
in vascular resistance at the onset of balloon inflation and the
incomplete restoration over time is not fully understood. Of inter-
est to the current study, Daley et al. (2003) demonstrated that an
increase in muscle sympathetic nerve activity (MSNA) can blunt
the restoration of flow to hypoperfused exercising muscle induced
by external positive pressure. An increased sympathetic restraint
in the microcirculation distal to a stenosis of a proximal artery
may have clinical implications as it suggests that conditions with
elevated MSNA might be more susceptible to hypoperfusion and
ischemia during exercise. Therefore, the aim of this study was to
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examine the contribution of α-adrenergic vasoconstriction in the
initial changes in vascular resistance at the onset of hypoperfusion
as well as in the recovery of flow over time.
MATERIALS AND METHODS
SUBJECTS
A total of nine young healthy male subjects volunteered to par-
ticipate in the study. Subjects gave written informed consent and
were non-obese, non-smokers, and were not taking any medica-
tions. Studies were performed after an overnight fast and after the
subjects refrained from exercise and caffeine for at least 24 h. All
study protocols were approved by Institutional Review Board and
in accordance with theDeclaration ofHelsinki. Other data collected
in this set of subjects has been previously reported by our group
(Casey and Joyner, 2009b).
HEART RATE AND SYSTEMIC BLOOD PRESSURE
Heart rate (HR) was measured by three-lead electrocardiography
(ECG). Systemic blood pressure was assessed (beat-to-beat) with
a finger plethysmograph (Finometer) on the non-exercising hand
and verified with an automated cuff on the same arm. The systemic
pressure was used as an index of pressure proximal (upstream)
from the balloon. Cardiac output (CO) was estimated using the
Modelflow technique which has been validated against other tech-
niques and used in exercise studies (Wesseling et al., 1993; Ogoh
et al., 2003).
ARTERIAL CATHETERIZATION AND BALLOON PLACEMENT
Brachial catheter placement and balloon insertion has been
described in detail previously (Casey and Joyner, 2009b). Briefly,
a 20-gage, 5 cm catheter was placed in the brachial artery in
the experimental arm using ultrasound guidance under aseptic
conditions after local anesthesia (2% lidocaine). A guide wire
was then placed in the artery which was then cannulated with
a four-French introducer (Cook Inc., Bloomington, IN, USA) that
permitted insertion of a two-French Fogarty balloon catheter into
the brachial artery. A port and stopcock system allowed the mea-
surement of arterial pressure, administration of study drugs and
drawing of arterial blood samples. The system was continuously
flushed (3 ml h−1) with heparinized saline. The configuration of
the balloon upstream from the lumen of the introducer allowed
measurement of the arterial pressure distal to the balloon that was
perfusing the contracting forearm muscles.
FOREARM BLOOD FLOW
Brachial artery mean blood velocity (MBV) and brachial artery
diameter were determined with a 12 MHz linear-array Doppler
probe (Model M12L, Vivid 7, General Electric, Milwaukee, WI,
USA). Brachial artery blood velocity was measured throughout
each condition with a probe insonation angle previously calibrated
to 60˚. Brachial artery and balloon diameter measurements were
obtained at end diastole and between contractions during steady-
state conditions. Diameter measurement typically results in the
loss of the pulse wave signal for 15–20 s. Therefore, brachial artery
diameters were not obtained for the target balloon inflation (nadir)
and the first 10 s immediately following balloon deflation (acute)
portions of the trial. The diameters obtained immediately prior
to each of these time points were used to calculate blood flow. It
should be noted that we have previously demonstrated that the
brachial artery diameter does not change in response to inflation
and deflation of the balloon at rest and during exercise (Casey and
Joyner, 2009b). Velocity and diameter measurements were made
2–3 cm proximal to the balloon. FBF was calculated as the product
of MBV (cm s−1) and brachial artery cross-sectional area (cm2)
and multiplied by 60 to present as milliliters per minute.
FOREARM EXERCISE
Rhythmic forearm exercise was performed with a hand grip device
by the non-dominant arm at 20% of each subject’s maximal vol-
untary contraction (MVC, mean 49± 2 kg, range 43–58 kg). The
weight was lifted 4–5 cm over a pulley at a duty cycle of 1 s
contraction/and 2 s relaxation (20 contractions per min) using
a metronome to insure correct timing. The average weight used
for forearm exercise was 9.9± 0.4 kg.
BRACHIAL ARTERY BALLOON INFLATION
To reduce FBF the brachial artery was partially occluded via
inflation of the Fogarty balloon catheter with saline using a cali-
brated microsyringe for tight control of balloon volume. Balloon
inflations were targeted to reduce MBV by 40–50%.
PHARMACOLOGICAL INFUSIONS
Phentolamine, a non-selective α-adrenergic antagonist, was
administered to the exercising forearm via brachial artery catheter
as a loading dose [10µg (dl forearm volume)−1 min−1 for 5 min]
followed by a continuous maintenance dose (50µg min−1). To
confirm α-adrenergic receptor blockade, tyramine was adminis-
tered [12µg (dl forearm volume)−1 min−1 for 3 min] to evoke
endogenous norepinephrine release and stimulate both α1- and
α2-adrenergic receptors before and after phentolamine (Frewin
and Whelan, 1968; Dinenno et al., 2002a,b).
EXPERIMENTAL PROTOCOL
A schematic of the general experimental design is illustrated in
Figure 1. Each subject completed a control (no drug) and an α-
adrenergic blockade (phentolamine) trial. Each trial consisted of
3 min of rest, exercise, exercise with balloon inflation, exercise fol-
lowing balloon deflation, and recovery (15 min total; 9 min of total
exercise). The phentolamine trials were always performed last due
to the drug’s half-life. Each trial was separated by 20 min of rest to
allow FBF to return to baseline.
DATA ANALYSIS AND STATISTICS
Data were collected at 200 Hz, stored on a computer and analyzed
off-line with signal processing software (WinDaq, DATAQ Instru-
ments, Akron, OH, USA). Local mean arterial pressure (BAP) was
determined from the brachial artery pressure waveform measured
distal to the balloon, systemic MAP (e.g., pressure proximal to
the balloon) was derived from the Finometer pressure waveform,
and HR was determined from the electrocardiogram. FBF, BAP,
MAP, CO, and HR were determined by averaging values during the
last 30 s of rest, exercise, exercise with inflation, exercise following
deflation, and recovery. In addition, all values were analyzed and
averaged during the first 10 s of target balloon inflation (nadir)
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FIGURE 1 | Schematic diagram of experimental protocol. Subjects
completed two trials. Each trial consisted of baseline, exercise (control),
exercise during inflation, exercise following deflation, and recovery
measurements (3 min each). Trials were performed during control (no drug)
and α-adrenergic receptor blockade (phentolamine). Each trial was separated
by at least 20 min of rest to allow FBF to return to baseline values. Tyramine
was infused with and without phentolamine to confirm the effectiveness of
α-adrenergic blockade.
and the first 10 s immediately following balloon deflation. FVC
was calculated as (FBF/BAP)× 100 and expressed as ml min−1
(100 mmHg)−1.
All values are expressed as means± SE. Within a given proto-
col, the FBF, FVC, BAP, systemic MAP, HR, and CO during rest,
exercise, the nadir after balloon inflation, exercise at the end of the
balloon inflation, exercise following deflation, and recovery were
analyzed by repeated measures analysis of variance (ANOVA).
When significance was detected, Tukey’s post hoc test was used
to identify individual differences and adjust P values to account
for multiple comparisons, to preserve an overall type I error rate
of 0.05.
Percent recovery in FBF and FVC were calculated (steady
state inflation plus exercise value− nadir)/[steady state exercise
(control) value− nadir]. To investigate the contribution of α-
adrenergic vasoconstriction on percentage recovery of blood flow
and conductance, paired t -tests were performed between drug
conditions (with and without phentolamine). To further explore
the contribution of local vasodilation to any restoration of flow, we
analyzed balloon resistance and forearm vascular resistance and
considered them individually and in series (O’leary and Sheriff,
1995; Casey and Joyner, 2009a,b). Using systemic arterial pressure
(SAP; Finometer), brachial artery pressure distal to the balloon
(BAP; catheter) and brachial artery blood flow, we calculated the
resistance of the balloon (SAP−BAP/flow) and vascular resis-
tance (BAP/flow). The total resistance was calculated as the sum
of these two resistors. Changes in vascular and balloon resistance
were analyzed from the onset of balloon inflation (nadir) until the
end of the inflation period and expressed as a percentage change.
One way repeated measures ANOVA were used to compare the
percentage change in resistance between drug conditions. Statis-
tical significance was set a priori at P < 0.05. Statistical analyses
were performed with SigmaStat 2.03 (SPSS, Inc.).
RESULTS
Eight of the nine subjects completed both of the exercise trials.
One subject did not complete the entire protocol due to technical
difficulties associated with the balloon during the phentolamine
trial and was excluded from the analysis. Those subjects included
in the group analysis were 29± 2 years of age, 180± 2 cm in height,
and weighed 82± 4 kg (BMI: 25± 1 kg m−2).
FOREARM BLOOD FLOW AND VASODILATION DURING EXERCISE WITH
BALLOON INFLATION
Group mean data for FBF and FVC responses are presented in
Table 1. As expected, exercise increased FBF and FVC in both
exercise trials (P < 0.01). Balloon inflation (nadir) during the exer-
cise trial with no drug acutely reduced FBF by 38% and FVC by
26% (P < 0.001). FBF and FVC at the end of inflation were par-
tially restored to exercise (control) levels, which were substantially
higher than their respective nadir values (P < 0.001). The per-
centage recovery of FBF and FVC during the exercise trials are
presented in Figures 2A,B.
IMPACT OF α-ADRENERGIC RECEPTOR BLOCKADE ON BLOOD FLOW
RECOVERY DURING HYPOPERFUSION
Infusion of phentolamine increased FBF and FVC throughout
the entire exercise trial compared to the control (no drug) trial
(P < 0.01–0.05; Table 1). Balloon inflation (nadir) during the
exercise trial with phentolamine acutely reduced FBF by 45% and
FVC by 28% (P < 0.001). The FBF and FVC at the end of infla-
tion under α-adrenergic receptor blockade were greater than the
values observed during the no drug trial (P < 0.01; Table 1). Con-
sequently, the percentage recovery of FBF and FVC during the trial
with phentolamine were substantially greater than the percentage
recovery values observed during the no drug trial (Figures 2A,B).
The time to reach steady state FBF during balloon inflation was
similar between the no drug and phentolamine trials (49± 5 vs.
47± 4 s; P = 0.48).
Acute balloon inflation caused similar increases in absolute
(0.06± 0.01 vs. 0.05± 0.01 mmHg ml min−1; P = 0.17) and
relative (31± 2% vs. 35± 5%; P = 0.41) vascular resis-
tance between the no drug and phentolamine trials. Vas-
cular resistance during balloon inflation (from nadir to
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Table 1 | Forearm blood flow and vasodilation during exercise with balloon inflation.
Baseline Exercise
(control)
Inflation
(nadir)
Inflation
(steady state)
Deflation
(acute)
Deflation
(steady state)
20% MVC (NO DRUG)
FBF (ml min−1) 95±25 468±33* 298±31*† 436±37*‡ 509±43*‡§ 501±37*‡§
FVC [ml min−1 (100 mmHg)−1] 107±27 520±42* 385±28*† 510±44*‡ 558±56*‡ 558±47*‡
20% MVC (PHENTOLAMINE)
FBF (ml min−1) 328±36a 657±70*a 383±49†b 642±70*‡a 755±88*‡§a 685±75*‡a
FVC [ml min−1 (100 mmHg)−1] 379±45a 737±85*a 544±62*†a 782±91*‡a 839±101*‡a 744±88*‡a
Values are means±SE. FBF, forearm blood flow; FVC, forearm vascular conductance; MVC, maximal voluntary contraction. *P<0.01 vs. baseline; †P<0.001 vs.
exercise (control); ‡P<0.001 vs. nadir; §P<0.05 vs. inflation (steady state); aP<0.01 vs. no drug trial; bP<0.05 vs. no drug trial.
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FIGURE 2 | Percentage recovery in forearm blood flow [FBF; (A)]
and forearm vascular conductance [FVC; (B)] during balloon
inflation. The percentage recovery in FBF and FVC was enhanced
under local α-adrenergic blockade during exercise with
hypoperfusion. *P < 0.05 vs. control (no drug); †P <0.01 vs. control
(no drug).
end of inflation) decreased during the no drug (0.27± 0.02
vs. 0.21± 0.02 mmHg ml min−1; P < 0.001), and phentolamine
(0.20± 0.02 vs. 0.14± 0.02 mmHg ml min−1; P < 0.01) trials.
Although the absolute reduction in vascular resistance was
similar between trials (P = 0.76), the percentage reduction in
vascular resistance was greater with phentolamine (−31± 2%
vs. −24± 2%; P < 0.01 vs. no drug trial). Balloon resis-
tance decreased (from nadir to end of inflation) in the no
drug (0.05± 0.01 vs. 0.02± 0.01 mmHg ml min−1; P < 0.01)
and phentolamine (0.05± 0.01 vs. 0.03± 0.01 mmHg ml min−1;
P < 0.01) trails. However the absolute (−0.03± 0.01 vs.
−0.03± 0.01; P = 0.93) and relative (−50± 8% vs. −49± 4%;
P = 0.91) changes in balloon resistance were not different between
drug conditions.
EFFECT OF α-ADRENERGIC RECEPTOR BLOCKADE ON VASCULAR
RESPONSES TO EXOGENOUS TYRAMINE
Tyramine caused a substantial reduction in FVC (87± 26 vs.
124± 25 ml min−1 (100 mmHg)−1; P < 0.001). α-Adrenergic
receptor blockade with phentolamine prevented a significant vaso-
constrictor response to tyramine (300± 33 vs. 318± 34 ml min−1
(100 mmHg)−1; P = 0.16). The relative tyramine-induced
reductions in FVC (with and without phentolamine) are presented
in Figure 3.
VASOCONSTRICTOR RESPONSIVENESS AND BLOOD FLOW RECOVERY
DURING HYPOPERFUSION
Figure 4 illustrates a strong relationship between the vasocon-
strictor responsiveness to endogenous norepinephrine release via
infusion of tyramine and the percentage FBF recovery during
forearm exercise with hypoperfusion. Subjects with greater vaso-
constrictor responsiveness to tyramine (i.e., greater reduction in
FBF) demonstrated a lower percentage FBF recovery.
HEMODYNAMIC CHANGES
Systemic hemodynamic responses during exercise are presented in
Table 2. Exercise resulted in an increase in MAP in both control (no
drug) and phentolamine trials (P < 0.05). MAP remained elevated
above baseline values throughout each trial (P < 0.05). Estimated
CO did not change with exercise (control) compared to baseline
in either trail, despite a slight increase in HR during the control
(no drug) trial. Compared to baseline values CO was elevated
during balloon inflation and deflation in the control (no drug
trial), whereas it was only elevated during the deflation period in
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FIGURE 3 | Effectiveness of phentolamine in blocking α-adrenergic
vasoconstriction. α-Adrenergic blockade via phentolamine substantially
reduced the vasoconstrictor responsiveness (∆ forearm vascular
conductance; FVC) to tyramine. *P <0.001 vs. control (no drug).
-50 -40 -30 -20 -10 0
%
 F
B
F
 r
e
c
o
v
e
ry
0
50
60
70
80
90
100
110
120
% FBF reduction during Tyramine
r = 0.937; P < 0.001
FIGURE 4 | Relationship between vasoconstrictor responsiveness and
percentage recovery in forearm blood flow (FBF) during
hypoperfusion. Vasoconstrictor responsiveness to endogenous
norepinephrine release via tyramine (percentage reduction in forearm blood
flow; FBF) is related to percentage recovery of FBF during balloon induced
hypoperfusion under control (no drug) conditions.
the phentolamine trial (P < 0.05). Important to the present study,
MAP, HR, and CO did not change with balloon inflation compared
to exercise (control) values in either trail.
DISCUSSION
The novel findings of our study are (1) α-adrenergic blockade
unmasks a greater compensatory vasodilation and flow recovery
to hypoperfused contracting muscle, (2) the initial increase in vas-
cular resistance at the onset of balloon inflation does not appear to
be α-adrenergic mediated, and (3) vasoconstrictor responsiveness
to endogenous norepinephrine is related to a lower flow recovery
during exercise with hypoperfusion.
Stimulation of chemosensitive afferents in contracting muscle
can elicit marked increases in MSNA to resting and active muscle
(Mark et al., 1985; Savard et al., 1987; Victor et al., 1987, 1988). The
increase in MSNA is further enhanced in hypoperfused and/or par-
tially ischemic contracting human muscle (Michikami et al., 2000;
Daley et al., 2003). Theoretically, the enhanced sympathetic drive
to the muscle and subsequent vasoconstriction could limit blood
flow to the active tissue. In the present study we examined whether
α-adrenergic vasoconstriction restrained flow during exercise with
hypoperfusion and possibly explained the incomplete compen-
satory flow response (<100% recovery) commonly observed in
our studies (Casey and Joyner, 2009a,b, 2011a,c). Our data demon-
strate that α-adrenergic blockade unmasks a substantial vasodila-
tion and restores blood flow to pre-inflation levels when compared
to control trials (97% vs. 80% recovery, respectively; Figure 2).
These findings suggest that sympathetic outflow during concur-
rent exercise and hypoperfusion partially limits the compensatory
vasodilation in the human forearm.
Interestingly, there is an absence of a significant pressor
response (above exercise alone) in our model of hypoperfusion
(Table 2), thus suggesting that balloon inflation and subsequent
hypoperfusion likely did not result in greater sympathetic out-
flow when compared to free flow exercise conditions. Therefore,
it may be possible that the α-adrenergic restraint observed with
hypoperfusion may be due to an exaggeratedα-adrenergic receptor
responsiveness in the partially ischemic tissue. Along these lines,
the relative vasoconstriction produced by α-adrenergic activity in
the coronary circulation of dogs during exercise is greater during
hypoperfusion (Laxson et al., 1989) than during normal arterial
inflow (Bache et al., 1988). It is also possible that an attenuated
functional sympatholysis might exist in the contracting muscle
when blood flow and oxygen delivery are compromised. However,
previous data form our group did not provide any evidence for
reduced vasoconstrictor responsiveness (augmented functional
sympatholysis) during hypoxic exercise (Wilkins et al., 2006).
Similar to our previous studies, vascular resistance increased at
the onset of balloon inflation. The findings of the present study
suggest that an enhanced α-adrenergic vasoconstriction at the
onset of balloon inflation does not explain the initial increase
in vascular resistance. In this context, α-adrenergic blockade did
not prevent the initial rise in vascular resistance when expressed
as absolute or relative changes. Although the reasons for the acute
increase in vascular resistance at the onset of balloon inflation in
our model of hypoperfusion are not completely clear it may be
related to dampening of pulsatile flow by balloon inflation. Along
these lines, pulsatile flow has been suggested to be a critical compo-
nent for the release of endothelium-derived vasodilators (Rubanyi
et al., 1986). Another possible explanation is that a sudden drop
in perfusion pressure causes resistance vessels to recoil before
autoregulatory vasodilation, a response that has been observed
during mild exercise in dogs (Koch et al., 1991). Lastly, alterations
in vascular bed compliance at the onset of balloon inflation may
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Table 2 | Systemic hemodynamic responses (n=8).
Baseline Exercise
(control)
Inflation
(nadir)
Inflation
(steady state)
Deflation
(acute)
Deflation
(steady state)
20% (CONTROL)
Mean arterial pressure (mmHg) 93±3 98±4* 99±4* 100±4* 100±4* 99±4*
Brachial artery pressure (mmHg) 90±2 91±3 79±3*‡ 86±2†‡ 91±2† 89±2†
Heart rate (beats min−1) 66±2 68±2* 68±2* 68±2* 68±2* 68±2*
Cardiac output (l min−1) 4.8±0.3 5.2±0.4 5.3±0.4* 5.3±0.3* 5.4±0.4* 5.5±0.4*
20% (PHENTOLAMINE)
Mean arterial pressure (mmHg) 93±4 97±3* 98±3* 100±3* 99±3* 101±3*
Brachial artery pressure (mmHg) 88±2 90±2 70±2*‡ 78±3*†‡ 90±2† 91±2†
Heart rate (beats min−1) 67±2 68±2 68±2 68±2 68±2 68±2
Cardiac output (l min−1) 5.1±0.3 5.4±0.4 5.5±0.4 5.5±0.5 5.6±0.5* 5.7±0.5*
Values are means± SE; *P<0.05 vs. baseline; †P<0.05 vs. nadir; ‡P< 0.05 vs. exercise (control).
also contribute to the acute increase in vascular resistance observed
in our model of hypoperfusion (Zamir et al., 2007).
In the current study we observed an extremely strong relation-
ship between the vasoconstrictor responsiveness to endogenous
norepinephrine release (via tyramine) and ability to restore blood
flow to the contracting muscle during exercise with hypoperfu-
sion (Figure 4). That is an individual with greater vasoconstrictor
responses to endogenous norepinephrine release demonstrated a
blunted recovery of flow during the period of exercise with balloon
inflation. This relationship suggests that the α-adrenergic tone
of the resistance vasculature in the forearm may play an impor-
tant role in the ability to compensate and restore blood flow to
underperfused skeletal muscle during exercise.
EXPERIMENTAL CONSIDERATIONS
The use of a non-specific α-adrenergic antagonist (phentolamine)
in the current study did not allow us to discern the relative
roles of α1- and α2-adrenergic receptors in the restriction of
compensatory vasodilation during forearm exercise with hypop-
erfusion. In young healthy men α2-adrenergic receptors have a
greater contribution to basal forearm vascular tone compared to
α1-adrenergic receptors (Dinenno et al., 2002b). However, in the
coronary circulation of dogs, α1- but not α2-adrenergic medi-
ated vasoconstriction limits blood flow distal to a coronary artery
stenosis (Laxson et al., 1989). Therefore, it is unclear whether α1
and α2-adrenergic mechanisms contribute differently to the vaso-
constrictor restraint of flow during exercise with hypoperfusion
in humans.
Administration of phentolamine altered baseline blood flow
and the absolute blood flow responses to the exercise. It could
be argued that these changes in flow before balloon infla-
tion may explain the enhanced flow recovery following α-
adrenergic blockade. However, the use of percent recovery (steady
state inflation plus exercise value− nadir)/[steady state exercise
(control) value− nadir] in the comparison between drug tri-
als clearly accounts for the differences in flow before balloon
inflation. Additionally, the reduction in flow caused by bal-
loon inflation still evoked compensatory vasodilation suggest-
ing that a metabolic error signal was present in spite of the
higher flow.
Our series of experiments (Casey and Joyner, 2009a,b, 2011a,c)
have consistently demonstrated that there is only a partial recov-
ery of FBF (<100%) during exercise with acute hypoperfusion
and this response is variable between subjects (see Figure 4 from
Casey and Joyner, 2011b). However, the percentage FVC recovery
tends to be greater than the percentage FBF recovery and in some
cases reaches and/or exceeds 100% (Casey and Joyner, 2011a). In
the current study the FVC recovery during the control trial was
91%, which was less than previously reported (Casey and Joyner,
2011a,c). The discrepancies in percentage FVC recovery between
studies might be related to the extent of collateral channels in
the forearm and magnitude of the restoration of distal perfusion
pressure in the subjects of each study. Despite the somewhat lower
percentage FVC recovery under control conditions in the current
study there was a substantial improvement during phentolamine
administration and supports the notion that α-adrenergic vaso-
constriction limits compensatory vasodilation and flow recovery
to hypoperfused contracting muscle.
CONCLUSION
This study demonstrates thatα-adrenergic mediated vasoconstric-
tion restricts compensatory vasodilation and flow during forearm
exercise with hypoperfusion. However, the initial rise in vascu-
lar resistance at the onset of hypoperfusion via balloon inflation
is not explained by an enhanced α-adrenergic vasoconstriction.
Taken together our findings suggest that α-adrenergic mediated
vasoconstriction plays an important role in the “less than per-
fect” compensatory flow response. Moreover, our data raise the
concern that patients with enhanced α-adrenergic vasoconstrictor
responsiveness might be more at risk to ischemia during exercise,
especially in vascular regions distal to a stenosis.
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